TABLE 1.
Time (h) of follow-up | Mean ± SE concn (μg/ml) of the indicated drug
|
||||||
---|---|---|---|---|---|---|---|
Group B, clarithromycin | Group C, clarithromycin | Group D, amikacin | Group E
|
Group F
|
|||
Clarithromycin | Amikacin | Clarithromycin | Amikacin | ||||
1 | 9.90 ± 1.28 | 13.00 ± 1.43 | 12.99 ± 4.07 | 7.33 ± 1.41 | 13.78 ± 4.71 | 10.50 ± 1.46 | 22.60 ± 4.22 |
2 | 7.13 ± 0.48 | 6.46 ± 0.63 | 13.45 ± 1.62 | 5.42 ± 0.78 | 13.90 ± 4.15 | 7.28 ± 0.47 | 17.69 ± 5.87 |
3 | 4.90 ± 0.50 | 15.38 ± 0.38 | —a | — | — | 13.50 ± 0.50 | 8.50 ± 1.50 |
24 | 1.05 ± 0.05 | NDb | ND | ND | ND | ND | ND |
—, no sampling was performed.
ND, not detectable.